During an infusion of albumin, the nurse monitors the patient closely for the development of which adverse effect?

Questions 30

ATI RN

ATI RN Test Bank

RN ATI Capstone Pharmacology 2 Quiz Questions

Question 1 of 5

During an infusion of albumin, the nurse monitors the patient closely for the development of which adverse effect?

Correct Answer: C

Rationale: Albumin is a plasma protein that helps maintain the oncotic pressure in the blood vessels and prevents fluid from leaking out into the tissues. During an infusion of albumin, there is a risk of fluid volume overload, especially in patients with existing heart failure or kidney disease. The nurse must monitor the patient closely for signs and symptoms of fluid volume overload, such as edema, shortness of breath, crackles in the lungs, and increased blood pressure. Prompt recognition and management of fluid volume overload are essential to prevent complications such as pulmonary edema and worsening heart failure. Hypernatremia and fluid volume deficit are unlikely to occur during an albumin infusion, and a transfusion reaction is not associated with albumin administration.

Question 2 of 5

During a blood transfusion, the patient begins to have chills and back pain. What is the nurse™s priority action?

Correct Answer: D

Rationale: The patient is exhibiting signs of a transfusion reaction, specifically indicating the possibility of a febrile non-hemolytic transfusion reaction. Chills and back pain are common symptoms of this type of reaction. The nurse's priority action in this situation is to discontinue the blood transfusion immediately to prevent further complications and potential harm to the patient. It is crucial to notify the prescriber promptly so that appropriate interventions can be initiated. Observing for other symptoms and slowing the infusion rate are important actions but may not be the priority in this scenario where the patient is experiencing signs of a possible transfusion reaction. It is not appropriate to tell the patient that these symptoms are a normal reaction, as they indicate a potential complication that needs immediate attention.

Question 3 of 5

Your patient is on the medication Lithium for bipolar I disorder. What major side effect should you monitor the patient for? ATI PHARMACOLOGY LATEST UPDATE 2022/2023 PROCTORED EXAM -STUDY GUIDE QUESTIONS & ANS 100% CORRECTLY VERIFIED GRADED A+ ATI PHARMACOLOGY LATEST UPDATE 2022/2023 PROCTORED EXAM -STUDY GUIDE QUESTIONS & ANS 100% CORRECTLY VERIFIED GRADED A+

Correct Answer: C

Rationale: One major side effect to monitor in a patient taking Lithium for bipolar I disorder is the risk of seizures. Lithium is known to lower the seizure threshold, increasing the likelihood of seizures occurring, especially if the patient has any pre-existing risk factors for seizures. Therefore, it is critical to closely monitor patients on Lithium for any signs or symptoms of seizures and promptly address them if they occur to prevent any complications. Monitoring lithium levels and maintaining them within the therapeutic range can also help reduce the risk of seizures.

Question 4 of 5

When giving digoxin (Lanoxin) to a patient, the health care provider notices various

Correct Answer: D

Rationale: Digoxin toxicity can lead to serious complications, such as arrhythmias and heart failure. Digibind, also known as digoxin immune fab, is a specific antidote used to treat severe cases of digoxin toxicity. It works by binding to digoxin in the body and forming a complex that is then excreted through the kidneys, effectively reversing the toxic effects of digoxin. Naloxone is used to reverse opioid overdose, Vitamin K is used to reverse warfarin overdose, and Fluemanzil is not a medication used for reversing digoxin toxicity.

Question 5 of 5

How can Ondansetron be administered? Select all that apply.

Correct Answer: A

Rationale: Ondansetron, commonly used to prevent nausea and vomiting, can be administered either orally (PO) or intravenously (IV). Both routes of administration are effective in delivering the medication to achieve the desired therapeutic effects. While options C (Subcutaneous) and D (IM) are not typically used for ondansetron administration, the correct answers are A (PO) and B (IV).

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions